To further assess the prognostic potential of CD24 amplification in BRCA, we performed the univariate and multivariate Cox regression analysis, including diagnosis age, tumor subtype, mutation count, TP53 mutant status and CD24 expression value. The gene discussed is TP53; the disease is neoplasm.